Expression of IL-2 and IL-11 and its significance in patients with ankylosing spondylitis

Asian Pacific Journal of Tropical Medicine

Volumn 6, Issue 1, 2013, Pages 76-78

  Liu, Feng ^a   Wang, Fan ^a   Wang, Cong Cong ^a   Li, Nuo ^a   Li, Shu Feng ^b  

^a Zhangqiu People's Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; IL 11; IL 2

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 11; INTERLEUKIN 2;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; BATH ANKYLOSING SPONDYLITIS METROLOGY INDEX; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-11; INTERLEUKIN-2; LINEAR MODELS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 84872458657     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60205-3     Document Type: Article

References (10)

1. Brown MA, Laval SH, Brophy S, Calin A Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000, 59:883-886.
2. Braun J, Sieper J Ankylosing spondylitis. Lancet 2007, 369:1379-1390.
3. Van der Linden S, Valkenburg HA, Cats A Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361.
4. Sarholz M, Vorgerd M, Braun J Camptocormia in the differential diagnosis of hyperkyphosis and ankylosing spondylitis. Dtsch Med Wochenschr 2012, 137(36):1736-1739.
5. Kroon F, Landewé R, Dougados M, van der Heijde D Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012, 71(10):1623-1629.
6. Ottaviani S, Allanore Y, Tubach F, Forien M, Gardette A, Pasquet B, et al. Body mass index influences the response to infliximab in ankylosing spondylitis. Arthritis Res Ther 2012, 14(3):R115.
7. Liu Y, Gao X, Deeb D, Arbab AS, Dulchavsky SA, Gautam SC Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation. J Exp Ther Oncol 2012, 10(1):1-8.
8. Höfer T, Krichevsky O, Altan-Bonnet G Competition for IL-2 between regulatory and effector T cells to Chisel immune responses. Front Immunol 2012, 3:268.
9. Cho N, Nguyen DH, Satkunendrarajah K Evaluating the role of IL-11, a novel cytokine in the IL-6 family, in a mouse model of spinal cord injury. J Neuroinflammation 2012, 9:134.
10. Shinohara Y, Ezura Y, Iwasaki H, Nakazawa I, Ishida R, Kodaira M, et al. Linkage disequilibrium and haplotype analysis among ten single-nucleotide polymorphisms ofinterleukin11 identified by sequencing of the gene. Hum Genet 2001, 46(8):494-497.